← Evidence map

ArticleIntegrated pharmacy research & practice2021

Response to "Considering the Potential Benefits of Over-the-Counter Naloxone" by Evoy et al [Letter].

Brian FuehrleinPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Full record →Abstract, authors, funding and every citing paper · PMID 34235054